Status
Conditions
Study type
Identifiers
About
The study started after the second COVID-19 vaccination of the participant with blood spots appearing on the skin with severe arthritis. The study continued to the third-dose full vaccination of the participant with the recombined COVID-19 vaccination and afterwards. The study completed until intervention.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
All COVID-19 vaccinated are eligible for inclusion.
1 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal